ORMP
Oramed Pharmaceuticals Inc
4.70$
-1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2003 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -6.7% | – | – | – | – | +283.2% | -0.3% | +10.4% | +0.3% | -0.3% | +0.0% | -50.4% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -61.8% | -54.0% | +4.7% | +0.0% | – | – | – | – | +929.5% | |
| – | – | – | – | – | – | – | – | -6.7% | – | – | – | – | +1,402.6% | +4.1% | +10.6% | +3.7% | -0.3% | +0.0% | -50.4% | -114.4% | – | |
| – | – | – | +1,019.6% | -46.9% | +29.5% | -3.8% | -20.8% | +45.0% | +35.2% | +44.2% | +45.9% | +61.2% | +33.4% | +16.5% | +12.9% | -24.3% | +105.1% | +31.7% | -67.5% | -29.5% | +0.9% | |
| – | -10.4% | +380.1% | +326.7% | +63.9% | -16.1% | +19.6% | -15.4% | -5.7% | +68.9% | +29.4% | -1.0% | -5.8% | +12.5% | +48.0% | -8.8% | +13.7% | +40.3% | +132.6% | -39.0% | -23.4% | +35.0% | |
| – | -10.4% | +821.4% | +658.6% | -14.4% | +3.9% | +6.8% | -18.1% | +18.4% | +49.2% | +37.2% | +25.0% | +37.6% | +28.3% | +23.2% | +7.4% | -16.1% | +86.1% | +60.8% | -60.5% | -25.3% | +18.2% | |
| – | – | – | – | – | – | – | – | – | -249.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -91.8% | +87,739.3% | -99.7% | +70.8% | -17.2% | +29.1% | +960.3% | +57.4% | -96.5% | – | – | -45.5% | +0.0% | +2,000.0% | – | – | +48,800.0% | +22.0% | -76.2% | -100.0% | |
| – | – | – | – | – | -206.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -412.9% | – | |
| – | – | +805.6% | +680.6% | -95.0% | -101.6% | – | -260.2% | – | -327.3% | – | -125.0% | – | -70.0% | -300.0% | – | -36.0% | -1,599.0% | – | – | – | +255.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -445.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -303.2% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.